295 related articles for article (PubMed ID: 25446841)
21. Plasmacytoid dendritic cells as a possible key player to initiate alopecia areata in the C3H/HeJ mouse.
Ito T; Suzuki T; Sakabe JI; Funakoshi A; Fujiyama T; Tokura Y
Allergol Int; 2020 Jan; 69(1):121-131. PubMed ID: 31431342
[TBL] [Abstract][Full Text] [Related]
22. Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(-) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse model.
McElwee KJ; Freyschmidt-Paul P; Hoffmann R; Kissling S; Hummel S; Vitacolonna M; Zöller M
J Invest Dermatol; 2005 May; 124(5):947-57. PubMed ID: 15854035
[TBL] [Abstract][Full Text] [Related]
23. C3H/HeJ mouse model for alopecia areata.
Sundberg JP; Boggess D; Montagutelli X; Hogan ME; King LE
J Invest Dermatol; 1995 May; 104(5 Suppl):16S-17S. PubMed ID: 7738375
[No Abstract] [Full Text] [Related]
24. Induction of alopecia areata in C3H/HeJ mice using cryopreserved lymphocytes.
Hashimoto K; Yamada Y; Sekiguchi K; Matsuda S; Mori S; Matsumoto T
J Dermatol Sci; 2021 Jun; 102(3):177-183. PubMed ID: 33994063
[TBL] [Abstract][Full Text] [Related]
25. Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans.
Carroll JM; McElwee KJ; E King L; Byrne MC; Sundberg JP
J Invest Dermatol; 2002 Aug; 119(2):392-402. PubMed ID: 12190862
[TBL] [Abstract][Full Text] [Related]
26. Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.
Gilhar A; Schrum AG; Etzioni A; Waldmann H; Paus R
Autoimmun Rev; 2016 Jul; 15(7):726-35. PubMed ID: 26971464
[TBL] [Abstract][Full Text] [Related]
27. Impaired autophagy promotes hair loss in the C3H/HeJ mouse model of alopecia areata.
Gund R; Christiano AM
Autophagy; 2023 Jan; 19(1):296-305. PubMed ID: 35652954
[TBL] [Abstract][Full Text] [Related]
28. Melanocyte and gonad activity as potential severity modifying factors in C3H/HeJ mouse alopecia areata.
McElwee KJ; Silva K; Beamer WG; King LE; Sundberg JP
Exp Dermatol; 2001 Dec; 10(6):420-9. PubMed ID: 11737261
[TBL] [Abstract][Full Text] [Related]
29. Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model.
Wikramanayake TC; Villasante AC; Mauro LM; Perez CI; Schachner LA; Jimenez JJ
Cell Stress Chaperones; 2012 Mar; 17(2):267-74. PubMed ID: 22042611
[TBL] [Abstract][Full Text] [Related]
30. Nonsurgical Induction of Alopecia Areata in C3H/HeJ Mice via Adoptive Transfer of Cultured Lymphoid Cells.
Wang EHC; McElwee KJ
Methods Mol Biol; 2020; 2154():121-131. PubMed ID: 32314212
[TBL] [Abstract][Full Text] [Related]
31. Hair follicle-derived mesenchymal stem cells decrease alopecia areata mouse hair loss and reduce inflammation around the hair follicle.
Deng W; Zhang Y; Wang W; Song A; Mukama O; Huang J; Han X; Deng S; Lin Z; Habimana JDD; Huang R; Peng K; Ni B; Zhang S; Yan X; Li J; Wu LP; Li Z
Stem Cell Res Ther; 2021 Oct; 12(1):548. PubMed ID: 34674748
[TBL] [Abstract][Full Text] [Related]
32. Comparison of alopecia areata in human and nonhuman mammalian species.
McElwee KJ; Boggess D; Olivry T; Oliver RF; Whiting D; Tobin DJ; Bystryn JC; King LE; Sundberg JP
Pathobiology; 1998; 66(2):90-107. PubMed ID: 9645633
[TBL] [Abstract][Full Text] [Related]
33. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
Gao Z; Jin YQ; Wu W
Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
[TBL] [Abstract][Full Text] [Related]
34. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata).
Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA
J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166
[TBL] [Abstract][Full Text] [Related]
35. A natural canine homologue of alopecia areata in humans.
Tobin DJ; Gardner SH; Luther PB; Dunston SM; Lindsey NJ; Olivry T
Br J Dermatol; 2003 Nov; 149(5):938-50. PubMed ID: 14632797
[TBL] [Abstract][Full Text] [Related]
36. Adult-onset Alopecia areata is a complex polygenic trait in the C3H/HeJ mouse model.
Sundberg JP; Silva KA; Li R; Cox GA; King LE
J Invest Dermatol; 2004 Aug; 123(2):294-7. PubMed ID: 15245428
[TBL] [Abstract][Full Text] [Related]
37. Mouse Models of Alopecia Areata: C3H/HeJ Mice Versus the Humanized AA Mouse Model.
Gilhar A; Laufer Britva R; Keren A; Paus R
J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S11-S15. PubMed ID: 33099377
[TBL] [Abstract][Full Text] [Related]
38. Whole exome sequencing in Alopecia Areata identifies rare variants in KRT82.
Erjavec SO; Gelfman S; Abdelaziz AR; Lee EY; Monga I; Alkelai A; Ionita-Laza I; Petukhova L; Christiano AM
Nat Commun; 2022 Feb; 13(1):800. PubMed ID: 35145093
[TBL] [Abstract][Full Text] [Related]
39. Selective Expansion of Tregs Using the IL-2 Cytokine Antibody Complex Does Not Reverse Established Alopecia Areata in C3H/HeJ Mice.
Lee E; Kim M; Lee YJ
Front Immunol; 2022; 13():874778. PubMed ID: 35799786
[TBL] [Abstract][Full Text] [Related]
40. [Alopecia areata in animal models--new insights into pathogenesis and treatment of a T cell-mediated autoimmune disorder].
Freyschmidt-Paul P; Happle R; Hoffman R
J Dtsch Dermatol Ges; 2004 Apr; 2(4):260-73. PubMed ID: 16285322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
